Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-β-en-α-ol (EO9) by human DT-diaphorase
- 13 December 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (11), 1711-1718
- https://doi.org/10.1016/s0006-2952(96)00521-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9JNCI Journal of the National Cancer Institute, 1996
- The Autoxidation of the Reduced Forms of EO9Free Radical Research, 1996
- Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxiaEuropean Journal Of Cancer, 1994
- Phase I and Pharmacologic Study of the Novel Indoloquinone Bioreductive Alkylating Cytotoxic Drug E09JNCI Journal of the National Cancer Institute, 1994
- Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent culturesEuropean Journal Of Cancer, 1993
- EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical modelsEuropean Journal Of Cancer, 1993
- Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymic reduction by DT-diaphoraseBiochemistry, 1992
- Cytosolic NAD(P)H:(Quinone‐acceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcoholInternational Journal of Cancer, 1990
- Purification by cibacron blue F3GA dye affinity chromatography and comparison of NAD(P)H:quinone reductase (E.C.1.6.99.2) from rat liver cytosol and microsomesBiochemical and Biophysical Research Communications, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976